Transition from intravenous epoprostenol to selexipag in pulmonary arterial hypertension: a word of caution.
Kenichi YanakaAlicia GuillienThibaud SoumagneJustin BenetNicolas PilieroFrançois PicardChristophe PisonOlivier SitbonHélène BouvaistBruno DeganoPublished in: The European respiratory journal (2020)